ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer-Reference-Cited by-同舟云学术

ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer

Published:2014-10-07 Issue:1 Volume:14 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Reese Jordan M,Suman Vera J,Subramaniam Malayannan,Wu Xianglin,Negron Vivian,Gingery Anne,Pitel Kevin S,Shah Sejal S,Cunliffe Heather E,McCullough Ann E,Pockaj Barbara A,Couch Fergus J,Olson Janet E,Reynolds Carol,Lingle Wilma L,Spelsberg Thomas C,Goetz Matthew P,Ingle James N,Hawse John R

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-14-749.pdf

Reference76 articles.

1. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, Naghavi M: Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011, 378 (9801): 1461-1484. 10.1016/S0140-6736(11)61351-2.

2. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996, 93 (12): 5925-5930. 10.1073/pnas.93.12.5925.

3. Mosselman S, Polman J, Dijkema R: ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996, 392 (1): 49-53. 10.1016/0014-5793(96)00782-X.

4. Osborne CK: Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat. 1998, 51 (3): 227-238. 10.1023/A:1006132427948.

5. Osborne CK, Schiff R: Estrogen-receptor biology: continuing progress and therapeutic implications. J Clin Oncol. 2005, 23 (8): 1616-1622. 10.1200/JCO.2005.10.036.

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumor effects of co-treatment of resveratrol with antitumor drugs in ER- and HER2-positive breast cancer cells are due to induction of apoptosis and modulation of estrogen receptor expression;Breast Cancer;2024-05-23

2. Estrogen Signals through ERβ in Breast Cancer; What We Have Learned since the Discovery of the Receptor;Receptors;2024-05-03

3. The Potential of Hormonal Therapies for Treatment of Triple-Negative Breast Cancer;Cancers;2023-09-24

4. Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival;BMC Cancer;2023-05-19

5. Disruption of estrogen receptor beta’s DNA binding domain impairs its tumor suppressive effects in triple negative breast cancer;Frontiers in Medicine;2023-02-28